英斯派尔医疗
INSP
68.79
-1.33
-1.90%
英斯派尔医疗
US · INSP
#2781 按市值排名
上市于 2018
68.79
-1.33
-1.90%
实时 - 追踪5344个代码 - 心跳于12秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量减少了2家。
- 机构持股总比例下降了0.4个百分点。
机构持股
- 机构持股比例
- 130.39% -0.36pp
- 机构数量
- 325 -2
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund73.91%
Hedge Fund36.36%
Public Company11.51%
Private Company5.67%
Government Pension Fund2.03%
Individual/Insider1.27%
Sovereign Wealth Fund0.69%
主要股东 截至 2026-06-30
BlackRock
16.39% · 4.74M 股
Wellington Management Group
8.24% · 2.38M 股
UBS Asset Management
7.58% · 2.19M 股
Vanguard Portfolio Management, LLC
7.23% · 2.09M 股
Soleus Capital Management, L.P.
6.68% · 1.93M 股
AQR Capital Management
6.41% · 1.85M 股
D. E. Shaw & Co., L.P.
5.09% · 1.47M 股
Vanguard Capital Management, LLC
5.06% · 1.46M 股
Nomura Holdings, Inc.
4.74% · 1.37M 股
Deerfield Management Company, L.P.
4.49% · 1.30M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 28次买入 · 21次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Timothy Herbert | Chief Executive Officer | 0.71% |
| Richard Buchholz | Chief Financial Officer | 0.15% |
| Shawn McCormick | Independent Director | 0.09% |
| Casey Tansey | Independent Director | 0.08% |
| Dana Mead | Independent Director | 0.07% |
| Bryan Phillips | Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary | 0.03% |
| Gary Ellis | Independent Director | 0.03% |
| John Rondoni | Chief Technology Officer | 0.02% |
| Shelley Broader | Independent Director | 0.02% |
| Georgia Garinois-Melenikiotou | Independent Director | 0.02% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-08-30 | Jason Kelly | Chief Manufacturing & Quality Officer | Other Acquisition | +6,350 | -- |
| 2026-08-06 | Jason Kelly | Chief Manufacturing & Quality Officer | Open Market Disposition | -963 | $59.55 |
| 2026-07-30 | Melissa Mann | Chief Human Resources Officer | Sale to Issuer | -652 | $50.21–124.54 |
| 2026-07-19 | Michael Carrel | Director | Other Acquisition | +5,631 | -- |
| 2026-07-14 | Casey Tansey | Independent Director | Other Acquisition | +346 | -- |
| 2026-07-14 | Shelley Broader | Independent Director | Other Acquisition | +383 | -- |
| 2026-07-14 | Gary Ellis | Independent Director | Other Acquisition | +581 | -- |
| 2026-07-14 | Georgia Garinois-Melenikiotou | Independent Director | Other Acquisition | +344 | -- |
| 2026-05-14 | John Rondoni | Chief Technology Officer | Open Market Disposition | -2,641 | $43.28 |
| 2026-05-13 | John Rondoni | Chief Technology Officer | Open Market Disposition | -700 | $43.01 |
| 2026-05-07 | Shawn McCormick | Independent Director | Open Market Disposition | -696 | $45.31 |
| 2026-04-30 | Georgia Garinois-Melenikiotou | Independent Director | Sale to Issuer | -50 | $56.70 |
| 2026-04-29 | Casey Tansey | Independent Director | Other Acquisition | +3,562 | -- |
| 2026-04-29 | Dana Mead | Independent Director | Other Acquisition | +3,562 | -- |
| 2026-04-29 | Shawn McCormick | Independent Director | Other Acquisition | +3,562 | -- |
| 2026-04-29 | Shelley Broader | Independent Director | Other Acquisition | +3,562 | -- |
| 2026-04-29 | Gary Ellis | Independent Director | Other Acquisition | +3,562 | -- |
| 2026-04-29 | Georgia Garinois-Melenikiotou | Independent Director | Other Acquisition | +3,562 | -- |
| 2026-04-29 | Myriam J. McAdams | Independent Director | Other Acquisition | +3,562 | -- |
| 2026-04-29 | Cynthia Burks | Independent Director | Other Acquisition | +3,562 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
英斯派尔医疗 讨论区 0 条评论